Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint Inhibitors
Clinical trial NCT04353765 · COMPLETED
Trial details
- NCT number
- NCT04353765
- Sponsor
- Ipsen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-30
- Primary completion
- 2020-06-05
- Enrollment
- 247
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.